Journal
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY
Volume 7, Issue 3, Pages E48-E51Publisher
OXFORD UNIV PRESS
DOI: 10.1093/ehjcvp/pvaa098
Keywords
Hypertension; Diabetes; Angiotensin-converting enzyme inhibitor (ACE-I); Angiotensin receptor blocker (ARB); Dipeptidyl peptidase 4 inhibitor (DPP4i)
Funding
- NMRC COVID-19 research fund [COVID19RF-001]
- A*STAR COVID-19 Research fund [H/20/04/g1/006]
- National Research Foundation [NRF2017_SISFP09]
- Ministry of Health, Clinician Scientist Award [MOH-000014]
- National Medical Research Council Centre Grant [NMRC/CG/017/2013]